Healthcare & Pharmaceuticals
Over one million people in the Canadian province of Quebec will receive a total of C$15.6 billion ($12.5 billion) in damages for smoking related diseases from three of the biggest tobacco companies in the country. The settlement is the result of a 17 year long court battle.
Why don't drug companies invest enough money in treating malaria and tuberculosis? A recent study published in the Lancet magazine estimates that 1,238,000 people died from malaria in 2010. Surely a wonder drug that stops these diseases would be wildly profitable?
On the opening day of the RNC, ACT UP members dropped a giant 30 by 75 foot banner from a highly visible location. The activists demand that George W. Bush take a stand against high drug prices that result in the deaths of millions of people with HIV in Africa and worldwide.
The World Health Organization (WHO) has barred a life sciences industry association from participating in setting global standards protecting food and water supplies because its members have a financial stake in the outcome.
Johnson & Johnson has been sued by over 1,200 women who blame the company's talcum powder products for their ovarian cancer. Not only are U.S. courts beginning to agree with them, juries have started to award victims millions of dollars in compensation.
Privatization of major medical laboratories from the National Hospital Service (NHS) in Britain has led to a dramatic decline in service quality, according to a "Transforming Pathology, the Serco way," a recent report from UK-based researchers Corporate Watch.
While 25 million Africans are living with AIDS, Northern pharmaceutical companies and governments are turning their back on the greatest tragedy of our time according to former deputy head of UNICEF.
In the final hectic days before Congress adjourns for the year, lobbyists are swarming around the Capitol, trying to adorn a bill on bioterrorism with all sorts of special-interest provisions.
Two years ago, when companies received a big tax break to bring home their offshore profits, the president and Congress justified it as a one-time tax amnesty that would create American jobs. Drug makers were the biggest beneficiaries of the amnesty program, repatriating about $100 billion in foreign profits and paying only minimal taxes. But the companies did not create many jobs in return. Instead, since 2005 the American drug industry has laid off tens of thousands of workers in thi
The Kazipally industrial area - once good farm country - now accounts for more than one-third of India's pharmaceutical industry, meaning skyrocketing rates of cancer, heart disease and birth defects for its residents.